Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Helene Højsgaard Chow"'
Autor:
Helen Dawes, Jesper Lundbye-Jensen, Tobias Sejbaek, Viktoria Papp, Ulrik Dalgas, Finn Sellebjerg, Lars G Hvid, Laurits Taul-Madsen, Jeppe Romme Christensen, Rikke Ratzer, Kristina Bacher Svendsen, Helene Højsgaard Chow
Publikováno v:
BMJ Open, Vol 14, Iss 8 (2024)
Introduction Multiple sclerosis (MS) causes a broad range of symptoms, with physical function being one of the most disabling consequences according to patients themselves. Exercise effectively improves lower extremity physical function. Nonetheless,
Externí odkaz:
https://doaj.org/article/9f41ba5b5dbf4cca938e747885bc466b
Autor:
Marina Rode von Essen, Helene Højsgaard Chow, Rikke Holm Hansen, Sophie Buhelt, Finn Sellebjerg
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Alemtuzumab is a monoclonal antibody targeting CD52 on the surface of immune cells, approved for the treatment of active relapsing-remitting multiple sclerosis (RRMS). The purpose of this study was to analyze the repopulation of peripheral lymphocyte
Externí odkaz:
https://doaj.org/article/0bc8462f76ff4996874bef66bfea3bf7
Autor:
Julie Schjødtz Hansen, Stefan Gustavsen, Homayoun Roshanisefat, Matthias Kant, Fin Biering-Sørensen, Claus Andersen, Anna Olsson, Helene Højsgaard Chow, Nasrin Asgari, Julie Richter Hansen, Helle Hvilsted Nielsen, Rikke Middelhede Hansen, Thor Petersen, Annette Bang Oturai, Finn Sellebjerg, Eva Aggerholm Sædder, Helge Kasch, Peter Vestergaard Rasmussen, Nanna Brix Finnerup, Kristina Bacher Svendsen
Publikováno v:
Pharmaceuticals, Vol 16, Iss 8, p 1079 (2023)
Patients with multiple sclerosis (MS) and spinal cord injury (SCI) commonly sustain central neuropathic pain (NP) and spasticity. Despite a lack of consistent evidence, cannabis-based medicine (CBM) has been suggested as a supplement treatment. We ai
Externí odkaz:
https://doaj.org/article/4eaeb1d85b0443b5ac6c45703acf19c2
Autor:
Helene Højsgaard Chow, Jacob Talbot, Henrik Lundell, Lisbet Marstrand, Camilla Gøbel Madsen, Helle Bach Søndergaard, Malene Bredahl Hansen, Per Solberg Sørensen, Hartwig Roman Siebner, Finn Sellebjerg
Publikováno v:
Chow, H H, Talbot, J, Lundell, H, Marstrand, L, Madsen, C G, Sondergaard, H B, Hansen, M B, Sorensen, P S, Siebner, H R & Sellebjerg, F 2023, ' Dimethyl fumarate treatment of primary progressive multiple sclerosis : results of an open-label extension study ', Multiple Sclerosis and Related Disorders, vol. 70, 104458 . https://doi.org/10.1016/j.msard.2022.104458
IntroductionDimethyl fumarate treatment is approved in Europe for patients with relapsing-remitting multiple sclerosis (MS) and in the US for relapsing forms of MS. We recently published the results of the first randomized placebo-controlled trial of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a611be734370427d2ab211b4fe9cfad
https://curis.ku.dk/portal/da/publications/dimethyl-fumarate-treatment-of-primary-progressive-multiple-sclerosis(83d0d61f-e236-4769-87b4-bc469fabd83a).html
https://curis.ku.dk/portal/da/publications/dimethyl-fumarate-treatment-of-primary-progressive-multiple-sclerosis(83d0d61f-e236-4769-87b4-bc469fabd83a).html
Autor:
Rikke Holm Hansen, Helene Højsgaard Chow, Jacob Talbot, Sophie Buhelt, Marie Nathalie Nickelsen Hellem, Jørgen Erik Nielsen, Finn Thorup Sellebjerg, Marina Rode von Essen
Publikováno v:
Multiple sclerosis (Houndmills, Basingstoke, England). 28(9)
Background: Peripheral helper T cells (Tph) are likely implicated in the pathogenesis of various inflammatory diseases. Tph cells share functions with follicular helper T cells, including plasma cell differentiation and antibody production. Objective
Autor:
Jacob Talbot, Helene Højsgaard Chow, Mie Mahler, Sophie Buhelt, Rikke Holm Hansen, Henrik Lundell, Tua Vinther-Jensen, Marie N.N. Hellem, Jørgen E. Nielsen, Hartwig Roman Siebner, Marina R. von Essen, Finn Sellebjerg
Publikováno v:
Talbot, J, Højsgaard Chow, H, Mahler, M, Buhelt, S, Holm Hansen, R, Lundell, H, Vinther-Jensen, T, Hellem, M N N, Nielsen, J E, Siebner, H R, von Essen, M R & Sellebjerg, F 2022, ' Relationship between cerebrospinal fluid biomarkers of inflammation and tissue damage in primary progressive multiple sclerosis ', Multiple Sclerosis and Related Disorders, vol. 68, 104209 . https://doi.org/10.1016/j.msard.2022.104209
Background and Objectives: It is unclear to what extent intrathecal inflammation contributes to the pathogenesis in primary progressive multiple sclerosis (PPMS). We conducted an exploratory study to investigate the degree of intrathecal inflammation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ccf2d47038048d606c060066ecb6a0f
https://curis.ku.dk/ws/files/323995524/1_s2.0_S2211034822007143_main.pdf
https://curis.ku.dk/ws/files/323995524/1_s2.0_S2211034822007143_main.pdf
Autor:
Rikke Holm Hansen, Jacob Talbot, Helene Højsgaard Chow, Malene Bredahl Hansen, Sophie Buhelt, Sebastian Herich, Nicholas Schwab, Marie Nathalie Nickelsen Hellem, Joergen Erik Nielsen, Finn Sellebjerg, Marina Rode von Essen
Publikováno v:
Holm Hansen, R, Talbot, J, Højsgaard Chow, H, Bredahl Hansen, M, Buhelt, S, Herich, S, Schwab, N, Hellem, M N N, Nielsen, J E, Sellebjerg, F & von Essen, M R 2022, ' Increased Intrathecal Activity of Follicular Helper T Cells in Patients With Relapsing-Remitting Multiple Sclerosis ', Neurology(R) neuroimmunology & neuroinflammation, vol. 9, no. 5, e200009. . https://doi.org/10.1212/NXI.0000000000200009
Background and ObjectivesFollicular helper T (Tfh) cells play a critical role in protective immunity helping B cells produce antibodies against foreign pathogens and are likely implicated in the pathogenesis of various autoimmune diseases. The purpos
Publikováno v:
Neurology-Neuroimmunology Neuroinflammation
Autor:
Jacob Talbot, Morten Blinkenberg, Lisbet Marstrand, Mie Reith Mahler, Marina Rode von Essen, Finn Sellebjerg, Per Soelberg Sørensen, Rikke Holm Hansen, Jeppe Romme Christensen, Theis Lange, Sophie Buhelt, Henrik Lundell, Helene Højsgaard Chow, Hartwig R. Siebner, Camilla Gøbel Madsen
Publikováno v:
Højsgaard Chow, H, Talbot, J, Lundell, H, Gøbel Madsen, C, Marstrand, L, Lange, T, Mahler, M R, Buhelt, S, Holm Hansen, R, Blinkenberg, M, Romme Christensen, J, Soelberg Sørensen, P, Rode von Essen, M, Siebner, H R & Sellebjerg, F 2021, ' Dimethyl Fumarate Treatment in Patients With Primary Progressive Multiple Sclerosis : A Randomized, Controlled Trial ', Neurology(R) neuroimmunology & neuroinflammation, vol. 8, no. 5, pp. 1-10 . https://doi.org/10.1212/NXI.0000000000001037
Background and ObjectiveTo study whether dimethyl fumarate is superior to placebo in decreasing CSF concentrations of neurofilament light chain (NFL) in patients with primary progressive MS (PPMS).MethodsIn the double-blind, placebo-controlled phase
Autor:
Helene Højsgaard Chow, Finn Sellebjerg, Marina Rode von Essen, Jeppe Romme Christensen, Rikke Holm Hansen
Publikováno v:
Multiple sclerosis and related disorders. 37
Background Dimethyl fumarate (DMF) is a disease-modifying therapy for patients with relapsing-remitting multiple sclerosis (RRMS). T cells are major contributors to the pathogenesis of RRMS, where they regulate the pathogenic immune response and part